Skip to main content
Gregory Yanik, MD, Pediatric Hematology & Oncology, Ann Arbor, MI

GregoryAnthonyYanikMD

Pediatric Hematology & Oncology • Ann Arbor, MI

Professor, Pediatrics & Communicable Diseases, University of Michigan Medical School

Join to view full profile

Dr. Yanik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yanik's full profile

Already have an account?

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1988 - 1991
  • Beaumont Health (Royal Oak)
    Beaumont Health (Royal Oak)Residency, Internal Medicine, 1984 - 1987
  • Beaumont Health (Royal Oak)
    Beaumont Health (Royal Oak)Internship, Transitional Year, 1983 - 1984
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1983

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1984 - 2026
  • OH State Medical License
    OH State Medical License 1988 - 1992
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
  • Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma  
    Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

  • Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
    Gregory Yanik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • H. Pylori May Hinder Efficacy of Immune Checkpoint Inhibitors
    H. Pylori May Hinder Efficacy of Immune Checkpoint InhibitorsAugust 4th, 2021
  • U-M Rogel Cancer Center First in Michigan to Offer All FDA Approved Car T-cell Therapies
    U-M Rogel Cancer Center First in Michigan to Offer All FDA Approved Car T-cell TherapiesMay 23rd, 2018
  • Mott Poised to Be Among First in the Nation to Offer Groundbreaking CAR-T Cell Therapy for Childhood Leukemia
    Mott Poised to Be Among First in the Nation to Offer Groundbreaking CAR-T Cell Therapy for Childhood LeukemiaAugust 31st, 2017

Grant Support

  • MIBG W/ Intensive Chemotheryapy &Autologous Stem Cell Rescue For NeuroblastemaNational Center For Research Resources2007
  • Etanercept For Treatment Of Sub-Acute Pulm Dysfunction After Allogeneic BMTNational Center For Research Resources2007
  • (MIBG) With Intensive Chemotheryapy And Autologous Stem Cell Rescue For NeuroblaNational Center For Research Resources2006
  • 131-I-Metaiodobenzylguanidine (131i-Mibg) Therapy For Refractory NeuroblastomaNational Center For Research Resources2004–2006
  • 131-1 MIBG In Combination With Chemotherapy For NeuroblastomaNational Center For Research Resources2000–2002

Dr. Gregory Yanik, Dr. Gregory Yanik, MD, Dr. G Yanik, Dr. Gregory Anthony Yanik